Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, Aug. 16, 2021 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent") (HKEX: 01801),…

USI Launches Dual-Core Bluetooth 5.0 Antenna-on-Package Module for Compact IoT Devices

SHANGHAI, Aug. 16, 2021 /PRNewswire/ — The ubiquity of IoT devices has proportionally increased the need…

LG Energy Solution to have 6-year access to nickel, cobalt from Australian Mines amid heated competition over raw materials

LG Energy Solution secures 71,000 tonnes of nickel and 7,000 tonnes of cobalt for stable supply…